Login / Signup

Pharmacological Basis of Differences in Dose Response, Dose Equivalence, and Duration of Action of Inhaled Corticosteroids.

Peter T Daley-YatesBhumika AggarwalMaximilian Plank
Published in: Advances in therapy (2024)
In a real-world clinical setting where there may be poor adherence to prescribed therapy, our findings suggest a significant therapeutic advantage for longer-acting ICS molecules in patients with asthma.
Keyphrases
  • chronic obstructive pulmonary disease
  • lung function
  • cystic fibrosis
  • type diabetes
  • adipose tissue
  • air pollution
  • mesenchymal stem cells
  • weight loss
  • smoking cessation